Additionally, low AMDHD1 expression was associated with adverse clinical characteristics such as poor tumor differentiation, presence of perineural invasion, elevated CA19-9 levels and advanced TNM stage (Fig. 1I and Table S3). The gene discussed is AMDHD1; the disease is neoplasm.